Top

Published in:

01-05-2017 | What's New in Intensive Care

An overview on severe infections in Europe

Authors: George Dimopoulos, Murat Akova

Published in: Intensive Care Medicine | Issue 5/2017

Excerpt

The latest developments on severe infections in the ICU could be summarized as the changed epidemiology of infections and pathogens, the emerging appearance of new resistant strains especially in war-ridden conditions, the upcoming new antibiotics, the use of alternative routes for antibiotics administration and the prolonged infusion of antibiotics. …

Doganay M, Demiraslan H (2016) Refugees of the Syrian civil war: impact on reemerging infection, health services, and biosecurity in Turkey. Health Sec 14:220–225CrossRef

ECDC (2016) Rapid risk assessment. Crimean Congo haemorrhagic fever in Spain. http://ecdc.europa.eu/en/publications/Publications/crimean-congo-haemorrhagic-fever-spain-risk-assessment.pdf. Accessed 6 Oct 2016

ECDC (2016) Communicable disease threats report. Week 41. http://ecdc.europa.eu/en/publications/Publications/communicable-disease-threats-report-15-oct-2016.pdf. Accessed 6 Oct 2016

Crum-Cianflone NF (2016) Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis 3(3):171CrossRef

Montagna MT, Lovero G, Borghi E et al (2014) Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of European literature from 2000 through 2013. Eur Rev Med Pharma Sci 18:661–674

Akova M (2016) Epidemiology of antimicrobial resistance in bloodstream infections. Virulence 7:252–266CrossRefPubMedPubMedCentral

Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH (2016) Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol 7:895PubMedPubMedCentral

Marston HD, Dixon DM, Knisley JM, Palmore TN, Fauci AS (2016) Antimicrobial resistance. JAMA 316:1193–1204CrossRefPubMed

Endimiani A, Jacobs MR (2016) The changing role of the clinical microbiology laboratory in defining resistance in Gram-negatives. Infect Dis Clin N Am 30:323–345CrossRef

10.

Vincent JL, Bassetti M, François B, Karam G, Chastre J, Torres A, Roberts J, Taccone FS, Rello J, Calandra T, De Backer D, Welte T, Antonelli M (2016) Advances in antibiotic therapy in the critically ill. Crit Care 20:133–146CrossRefPubMedPubMedCentral

11.

Cassir N, Rolain JM, Brouqui P (2014) A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol 20(5):551

12.

Nicolau DP, Dimopoulos G, Welte T, Luyt CE (2016) Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit? Expert Rev Respir Med 10(8):907–918CrossRefPubMed

13.

Dugernier J, Wittebole X, Roeseler J, Michotte JB, Sottiaux T, Dugernier T, Laterre PF, Reychler G (2015) Influence of inspiratory flow pattern and nebulizer position on aerosol delivery with a vibrating-mesh nebulizer during invasive mechanical ventilation: an in vitro analysis. J Aerosol Med Pulm Drug Deliv 28(3):229–236CrossRefPubMed

14.

Kollef MH, Ricard JD, Roux D, Francois B, Ischaki E, Rozgonyi Z, Boulain T, Ivanyi Z, János G, Garot D, Koura F, Zakynthinos E, Dimopoulos G, Torres A, Danker W, Montgomery AB (2016) A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-negative ventilator-associated pneumonia: IASIS Trial. Chest 16:62463–62467. doi:10.1016/j.chest.2016.11.026

15.

Abdul-Aziz MH, Lipman J, Akova M, Bassetti M, De Waele JJ, Dimopoulos G et al (2016) DALI Study Group. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved PK/PD and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort. J Antimicrob Chemother 71(1):196–207CrossRefPubMed

16.

Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, DALI Study (2014) DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58(8):1072–1083CrossRefPubMed

Title: An overview on severe infections in Europe
Authors: George Dimopoulos
Murat Akova
Publication date: 01-05-2017
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 5/2017
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-016-4650-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

An overview on severe infections in Europe

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2017

Magnet guidance reduces misplacement of subclavian vein catheter in internal jugular vein

A “UFO” in the right pulmonary artery after cardiac surgery

How much excess fluid impairs outcome of sepsis?

Association of do-not-resuscitate order and survival in patients with severe sepsis and/or septic shock

Statins in patients with sepsis and ARDS: is it over? Yes

Compliance and statistics